WO2003025142A3 - Novel nucleic acids and secreted polypeptides - Google Patents

Novel nucleic acids and secreted polypeptides Download PDF

Info

Publication number
WO2003025142A3
WO2003025142A3 PCT/US2002/029636 US0229636W WO03025142A3 WO 2003025142 A3 WO2003025142 A3 WO 2003025142A3 US 0229636 W US0229636 W US 0229636W WO 03025142 A3 WO03025142 A3 WO 03025142A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
novel nucleic
secreted polypeptides
novel
secreted
Prior art date
Application number
PCT/US2002/029636
Other languages
French (fr)
Other versions
WO2003025142A2 (en
Inventor
Y Tom Tang
Vinod Asundi
Ryle W Goodrich
Feiyan Ren
Jie Zhang
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Tom Wehrman
Gezhi Weng
Ping Zhou
Radoje T Drmanac
Original Assignee
Nuvelo Inc
Y Tom Tang
Vinod Asundi
Ryle W Goodrich
Feiyan Ren
Jie Zhang
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Tom Wehrman
Gezhi Weng
Ping Zhou
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc, Y Tom Tang, Vinod Asundi, Ryle W Goodrich, Feiyan Ren, Jie Zhang, Qing A Zhao, Jian-Rui Wang, Malabika Ghosh, Aidong J Xue, Tom Wehrman, Gezhi Weng, Ping Zhou, Radoje T Drmanac filed Critical Nuvelo Inc
Priority to AU2002343380A priority Critical patent/AU2002343380A1/en
Priority to CA002460611A priority patent/CA2460611A1/en
Priority to EP02780320A priority patent/EP1487988A4/en
Publication of WO2003025142A2 publication Critical patent/WO2003025142A2/en
Publication of WO2003025142A3 publication Critical patent/WO2003025142A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2002/029636 2001-09-16 2002-09-18 Novel nucleic acids and secreted polypeptides WO2003025142A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002343380A AU2002343380A1 (en) 2001-09-18 2002-09-18 Novel nucleic acids and secreted polypeptides
CA002460611A CA2460611A1 (en) 2001-09-18 2002-09-18 Novel nucleic acids and secreted polypeptides
EP02780320A EP1487988A4 (en) 2001-09-18 2002-09-18 Novel nucleic acids and secreted polypeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24581701A 2001-09-16 2001-09-16
US32334901P 2001-09-18 2001-09-18
US60/323,349 2001-09-18
US10/245,817 2002-09-16

Publications (2)

Publication Number Publication Date
WO2003025142A2 WO2003025142A2 (en) 2003-03-27
WO2003025142A3 true WO2003025142A3 (en) 2004-10-21

Family

ID=33161822

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/029636 WO2003025142A2 (en) 2001-09-16 2002-09-18 Novel nucleic acids and secreted polypeptides

Country Status (1)

Country Link
WO (1) WO2003025142A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237367A1 (en) 2002-06-03 2003-12-19 Chiron Corporation Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
PL2157192T3 (en) 2003-10-10 2014-01-31 Deutsches Krebsforsch Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins)
US8119772B2 (en) * 2006-09-29 2012-02-21 California Institute Of Technology MART-1 T cell receptors
US8088374B2 (en) 2006-10-20 2012-01-03 Deutsches Krebsforschungszentrum Stiftung Des Offenlichen Rechts Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists
US20100196351A1 (en) * 2007-02-15 2010-08-05 Geneswitch Innovations Llc Secreted pate-like proteins
WO2009001555A1 (en) * 2007-06-26 2008-12-31 National University Corporation Hokkaido University Expression controller of type i interferon
AR121035A1 (en) 2019-04-01 2022-04-13 Lilly Co Eli NEUREGULIN-4 COMPOUNDS AND METHODS OF USE

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 9 October 2000 (2000-10-09), XP002979584, accession no. NCBI Database accession no. AV712481 *
See also references of EP1487988A4 *

Also Published As

Publication number Publication date
WO2003025142A2 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO1999057132A8 (en) Secreted proteins and polynucleotides encoding them
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides
WO2001075068A3 (en) Secreted proteins and polynucleotides encoding them
WO2005049806A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2460611

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002780320

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002780320

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002780320

Country of ref document: EP